Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 352

The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.

JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease

Open access
Nakamura, Masato, Kimura, Kazuo, Kimura, Takeshi, Ishihara, Masaharu, Otsuka, Fumiyuki, Kozuma, Ken, Kosuge, Masami, Shinke, Toshiro, Nakagawa, Yoshihisa, Natsuaki, Masahiro, Yasuda, Satoshi, Akasaka, Takashi, Kohsaka, Shun, Haze, Kazuo, Hirayama, Atsushi·2020·Circulation Journal

Abstract

CConsensus from expert opinion and/or small clinical trials (including retrospective studies and case series).Scoring systems for making a comprehensive judgment on DAPT duration have been developed outside Japan.The PRECISE-DAPT score seeks to predict the bleeding risk during DAPT, and is calculated before PCI from age, history of bleeding, white blood cell count, hemoglobin, and creatinine clearance (Ccr).5 The DAPT score, the classical version prior to PRECISE-DAPT, is intended for use during the chronic phase of therapy at 1 year post-PCI and is increased with smoking, diabetes mellitus, prior myocardial infarction, prior PCI, paclitaxel-eluting stent implantation, stent diameter <3 mm, heart failure or left ventricular ejection fraction (LVEF) <30%, and vein graft stent, whereas higher age decreases the score.The DAPT score simultaneously estimates both bleeding and thrombotic risk.Studies have shown that, in patients with higher DAPT scores, continued use of DAPT reduced death and cardiovascular events, including myocardial infarction and stroke, without increasing bleeding events (Table 3).11,15,17 The DAPT score has also been reported to be applicable to Japanese patients.18 Of note, in the DAPT study that serves as the basis for calculating this score, patients who had bleeding events within the first year after PCI were excluded, and therefore this score is applicable only to low-risk patients who tolerated DAPT for 1 year after PCI.Prediction of risks for bleeding and thrombotic events immediately after PCI is more important than at ≥1 year after PCI, but enough evidence has not yet been obtained regarding this period.Therefore, care should be taken in applying those scoring systems developed outside Japan to Japanese clinical practice.In addition to the DAPT and PRECISE-DAPT scores, there are various bleeding risk scoring systems from the PARIS Registry, 19 ADAPT-DES study, 20 HORIZON AMI study, 21 CRUSADE study, 22 etc.The PARIS score derived from the PARIS Registry includes scores of not only bleeding risk but also thrombotic risk (Table 4).The common independent predictors of bleeding risk in those studies included chronic kidney disease (CKD), peripheral vascular disease, heart failure, and use of anticoagulants (or atrial fibrillation [AF]).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1253/circj.cj-19-1109

Cites

179 of 179 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 179 references

Cited by

See all 352

Metadata

Authors
Nakamura, M., Kimura, K., Kimura, T., Ishihara, M., Otsuka, F., Kozuma, K., Kosuge, M., Shinke, T., Nakagawa, Y., Natsuaki, M., Yasuda, S., Akasaka, T., Kohsaka, S., Haze, K., & Hirayama, A.
Venue
Circulation Journal
Published
2020-04-24
Volume
84
Issue
5
Pages
831-865
ISSN
  • 1346-9843 (ISSN-L)
  • 1347-4820
OpenAlex
W3012340745
Cited by
352
References
179
FWCI
27.93
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease. https://app.cochat.ai/papers/10.1253/circj.cj-19-1109
The paper
Nakamura, M., Kimura, K., Kimura, T., Ishihara, M., Otsuka, F., Kozuma, K., Kosuge, M., Shinke, T., Nakagawa, Y., Natsuaki, M., Yasuda, S., Akasaka, T., Kohsaka, S., Haze, K., & Hirayama, A. (2020). JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease. Circulation Journal. https://doi.org/10.1253/circj.cj-19-1109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.